Literature DB >> 29573660

Development, validation and cultural-adaptation of the knowledge about psychosis questionnaire for African-Caribbean people in the UK.

Amy Degnan1, Katherine Berry2, Susannah James3, Dawn Edge4.   

Abstract

The absence of assessment tools incorporating different cultural models of mental illness is a major barrier to recruiting ethnic minorities into clinical trials, reducing generalisability of findings and potentially increasing disparities in access to evidence-based care. This study aimed to develop and validate a new Knowledge about Psychosis (KAP) self-report measure and a culturally-adapted version for African-Caribbean people (CaKAP). Content and face validity were achieved through consultations with experts in psychosis and a focus group with service users, carers, and community members. Eighty-seven predominantly White British participants and 79 African-Caribbean participants completed the knowledge questionnaires (KAP and CaKAP) and measures of help-seeking and stigma. Overall, the measures showed good internal consistency and test re-test reliability. Construct validity was evidenced via significant positive associations between knowledge about psychosis and help-seeking and significant negative associations between knowledge and stigma. These measures could improve the delivery of psychosocial interventions and outcome measurement in research trials. Crown
Copyright © 2018. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29573660     DOI: 10.1016/j.psychres.2018.03.013

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  Co-production and evaluation of an e-learning resource to improve African-Caribbean families' knowledge about schizophrenia and engagement with services: a pilot randomised controlled trial protocol.

Authors:  Henna Lemetyinen; Juliana Onwumere; Richard James Drake; Kathryn Abel; Carol Haigh; Georgina Moulton; Dawn Edge
Journal:  Pilot Feasibility Stud       Date:  2018-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.